Sign in

CIK 0001130598

  • Non-accelerated filer
  • Smaller reporting company

Traws Pharma, Inc.

Sign in to watch
Ticker
TRAW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 267-759-3680
Business address
12 PENNS TRAIL, NEWTOWN, PA, 18940
Former names
Onconova Therapeutics, Inc., ONCONOVA THERAPEUTICS INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Open-market buy Director bought 10,000 shares at $0.36 ($3,626)
  6. 4 Open-market buy SVP Corp Dev & Gen Counsel bought 15,000 shares at $0.37 ($5,550)
  7. 4 Open-market buy Chief Financial Officer bought 21,000 shares at $0.36 ($7,560)
  8. 4 Open-market buy President, Chief Executive Off bought 26,800 shares at $0.37 ($9,857)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market buy Director bought 250,000 shares at $0.20 ($50,000)
  15. 4 Open-market buy Director bought 500,000 shares at $0.20 ($100,000)
  16. 4 Open-market buy Director bought 150,000 shares at $0.20 ($30,000)
  17. 4 Open-market buy President, Chief Executive Off bought 149,000 shares at $0.20 ($29,800)
  18. 4 Open-market buy Chief Financial Officer bought 87,500 shares at $0.20 ($17,500)
  19. 4 Open-market buy VP Corp Dev & Gen Counsel bought 75,000 shares at $0.20 ($15,000)
  20. 4 Open-market buy Director bought 7,260 shares at $1.60 ($11,616)

Page 9 of 19 · 373 filings